clinical trial · NCT07623668
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Oculis·phase3·recruiting·n = 210
Optic NeuritisPrivosegtorMethylprednisolonePlacebo
brief summary
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).
started
May 28, 2026
primary completion
Dec 1, 2027
completion
Dec 1, 2028
last updated
Jul 1, 2026
official title
A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol